Immunoregulation of lymphokine-activated killer cells.
نویسندگان
چکیده
The in vitro effects of Concanavalin A (Con A) and prednisolone (PRD) on the cytotoxic functions of lymphocytes and the generation of lymphokine-activated killer (LAK) cells were investigated. Con A at concentrations ranging from 1 to 40 micrograms/ml did not significantly affect the cytotoxicity of LAK cells when added directly to the effector and target cell mixture in a 4-hr 51Cr release assay. The generation and lytic capacity of LAK cells were significantly affected by Con A in a dose-dependent manner when lectin was added at the initiation of culture. Suppression of LAK cell activity was demonstrable at effector: target (E:T) cell ratios. Lymphocyte cultures incubated with PRD at concentrations ranging from 10(-9) to 10(-4) M showed a decrease in both the numbers of and activity of LAK cells using a variety of target cells. Pretreatment of target cells with either PRD or Con A did not affect their sensitivity to lysis by LAK cells and incubation of lymphocytes with Con A did not induce autoreactive cytotoxic or suppressor cells directed against LAK cell activity. Thus while PRD and Con A can inhibit the generation of LAK cells, they also directly inhibit their specific cytotoxic activity on a per cell basis. These results suggest that like other cytotoxic cells, LAK cells are also under active immunologic control.
منابع مشابه
Immunoregulation of natural and lymphokine-activated killer cells by selenium.
The effect of selenium (Se) on natural killer (NK) and lymphokine-activated killer (LAK) cell activities and proliferative responses of human lymphocytes was studied in vitro. Direct addition of Se at 1.0 microgram/ml final concentration to the mixture of target and effector cells during a 4 h cytotoxicity assay significantly suppressed the NK activity of normal lymphocytes. When lymphocytes we...
متن کاملLysis of human alveolar macrophages by lymphokine-activated killer cells.
In order to determine if human LAK cells were cytotoxic against autologous AM phi, we studied the ability of human peripheral blood MNCs, stimulated in vitro with recombinant human IL-2, to lyse AM phi in a four-hour 51Cr-release assay. These cells showed significant cytotoxicity against autologous AM phi. The AM phi which had been cultured for four days served as better targets than freshly is...
متن کاملChronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?
Major depression is a stress-related disorder that affects about 20% of the population, with women outnumbering men by 2:1. However, research focusing on stress/antidepressant-related immunomodulation overlooks sex differences, although an established sexual dimorphism also characterizes the immune system. We report for the first time that both chronic clomipramine treatment (10 mg/kg, twice da...
متن کاملLymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Purified interleukin 2 (IL-2) was found to be sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer (LAK) cells. The LAK activation factor was directly and consistently associated with IL-2 activity using classic protein purification techniques, adsorption to IL-2-dependent cell lines, and inhibition with anti-Tac antibody. As yet, no other cytokines ...
متن کاملInteraction of fibrinogen with murine melanoma cells: covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells.
B16/F10 melanoma cells, in a medium containing fibrinogen, form a coating of fibrin(ogen) on their surfaces. This coating is cross-linked in a manner characteristic of catalysis by cellular transglutaminase. The fibrin(ogen) coating on the surface of these tumor cells provides protection against the lytic effect of autologous lymphokine-activated killer cells.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical immunology and immunopathology
دوره 49 1 شماره
صفحات -
تاریخ انتشار 1988